EUROPEAN GLAUCOMA RESEARCH TRAINING PROGRAM FOR ACCELERATING THE APPROACH TO ADVANCED GLAUCOMA
| Title | EUROPEAN GLAUCOMA RESEARCH TRAINING PROGRAM FOR ACCELERATING THE APPROACH TO ADVANCED GLAUCOMA |
|---|---|
| Acronym | EGRET-AAA |
| Website | www.egret-aaa.eu |
| Start date | 2023-02-01 |
| End date | 2027-12-31 |
| Sponsor | Horizon Europe |
| Institution | University Medical Center Groningen |
Associated cell lines
- AUMCi001-A (LUMC0195iFOXC)
- CRTDi004-A (CRTD1)
- LUMCi030-A (LUMC0110iALK04)
- TMOi001-A (Gibco Episomal iPSC Line; A18945)
- WAe001-A (H1, WA01)
Project Description
Glaucoma is the most common age-related neurodegenerative eye disease in Western society and one of the four major eye diseases causing blindness. Unfortunately, current treatments can only slow the deterioration but do not halt or reverse the process. Despite the efforts of early detection and treatment of the disease, currently, approximately 15% of all glaucoma patients in the EU still become bilaterally blind. Our European MARIE SKŁODOWSKA-CURIE Doctoral Network (DN) EGRET-AAA (‘European Glaucoma REsearch Training program for Accelerating the Approach to Advanced Glaucoma‘) will focus specifically on finding solutions for those patients suffering from advanced glaucoma. We aim to bring revolutionary therapies for protecting and restoring vision in patients with advanced glaucoma a significant step closer to clinical deployment.